geneticXchange Corporate Overview
Who We AreMarket Need
Our Approach
Select Customers
Key Company Facts
Who We Are
geneticXchange is dedicated to helping biotech companies re-shape the drug discovery process by providing innovative tools and technologies that make informaticists' and researchers' jobs easier and more productive. How? Through our discoveryHub product - robust and powerful data integration software specially designed to handle the volume and complexity of life science data, which is characterized by widely disparate formats, structures and locations. The result is increased productivity, reduced risk and accelerated time-to-market for critical drug discovery initiatives.Market Need
One of the biggest challenges in bioinformatics and drug discovery today is data access and integration. This issue has become a major bottleneck to R&D productivity for many biotechnology and pharmaceutical companies. The challenge exists because biological data sources are geographically distributed, complex and heterogeneous in data types and structures, and are constantly changing. With the unprecedented growth of genomic, proteomic, and other types of scientific data, the challenge now is how large volumes of data can first be retrieved from multiple databases, files, and instruments and then transformed and integrated automatically and flexibly. This process is critical for turning data into knowledge - the crown jewel of drug discovery. geneticXchange uniquely enables companies to fully exploit this valuable asset by providing a robust data integration platform to underpin and thereby facilitate all drug research and development initiatives. IDC research predicts that by 2006, $38B will be spent on IT for life sciencesOur Approach
To date, scientists and bioinformaticists have been forced to hand-code data access and integration tools in order to conduct scientific queries and research. This has created huge IT inefficiencies and has slowed the discovery process. The result is a limited data set that rapidly becomes out of date as data sources change and expand. geneticXchange architected a solution from the ground up that supports virtually any scientific data sources and offers an embeddable architecture, for the ultimate flexibility and performance in any environment. With the discoveryHub product, scientists and their IT support organization get a complete biological data integration platform with a familiar SQL interface. On the back-end, discoveryHub provides a powerful engine that efficiently collects, transforms, integrates and loads scientific data from both internal and external sources in a secure and private manner. On the front-end, the discoveryBuilder user interface enables researchers and scientists to conduct complex, ad-hoc, real-time queries against an unlimited number of data sources, instantly.Unique Advantages:
- Pre-built 'wrappers' for 60+ leading biological data sources, including a "test harness" that is run daily to maintain the integrity of all wrappers as data sources change
- Wrapper Generator Kit - enables new sources to be added in a matter of days instead of weeks or months as with hand-coded or competitive alternatives
- systems architecture - to fit seamlessly in any environment and leverage existing technology investments and IT skills
- Ability to handle complex nested data structures, common in life sciences data, as a single object so it can be easily integrated into a relational environment, without the need for flattening, for significantly improved IT performance and scalability
 |
discoveryHub provides the missing 'informatics platform' across all business silos and data sources |
Select Customers
geneticXchange customers include Genomics Collaborative, Inc., the Genome Institute of Singapore, and Signature BioScience. We also have strong collaborations with a leading pharmaceutical company, the $180M European GRID project, and the Universities of Pennsylvania, San Diego, Stanford, Georgetown, Manchester and Singapore.Key Company Facts
FOUNDED August, 1998 BACKED BY SOFTBANK Life Sciences
EDB of SingaporePRODUCT HISTORY Development began: 1994
Academic production: 1995
Commercial production: 2001LOCATIONS IN Menlo Park, CA
London, U.K.
Sydney, AustraliaWE SELL TO Biotech companies around the world who utilize the technology:-
- For in-house drug discovery - As an embedded component of their drug discovery platforms
- Instrument vendors who utilize the technology to increase reagent and instrument sales by eliminating the data analysis bottleneck
PARTNERS WITH
- IBM
- Oracle
- Sun Microsystems
"We believe data integration technologies like discoveryHub will break down existing barriers to drug discovery and development, paving the way to a significant step-change in the way scientific data is transformed into knowledge and utilized for creating new drugs faster, cheaper, and more effectively than ever before."
Brian Donnelly
CEO